Matches in Wikidata for { <http://www.wikidata.org/entity/Q92123654> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92123654 description "article scientifique publié en 2019" @default.
- Q92123654 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q92123654 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92123654 description "scientific article published on 17 January 2019" @default.
- Q92123654 description "wetenschappelijk artikel" @default.
- Q92123654 description "наукова стаття, опублікована 17 січня 2019" @default.
- Q92123654 name "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 name "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 type Item @default.
- Q92123654 label "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 label "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 prefLabel "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 prefLabel "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 P1433 Q92123654-E0BB7BBB-3009-4A70-829C-2AB40231F117 @default.
- Q92123654 P1476 Q92123654-789AE636-AF54-48B3-8DF4-5C117CE50A27 @default.
- Q92123654 P2093 Q92123654-06109629-69FC-4340-A331-167396781E9D @default.
- Q92123654 P2093 Q92123654-06DFFD78-6D94-4B9A-A680-037FE5B12090 @default.
- Q92123654 P2093 Q92123654-6CAE64B5-5DBD-44EB-97BF-027B341C5FEE @default.
- Q92123654 P2093 Q92123654-941BF718-5E24-4761-A1B7-E6BF84569A62 @default.
- Q92123654 P2093 Q92123654-94780D8F-7F8E-406C-9BFD-0FAB71AFBEB2 @default.
- Q92123654 P2093 Q92123654-95578E81-7568-4D08-8007-5967F58DEEAD @default.
- Q92123654 P2093 Q92123654-C392DE0A-9764-40EF-BA55-6B6B07853E91 @default.
- Q92123654 P304 Q92123654-29639F5C-C9E3-4548-9A4E-782393D16DB2 @default.
- Q92123654 P31 Q92123654-D1B0EEA4-3C57-490D-8B95-C514ADE24A09 @default.
- Q92123654 P356 Q92123654-82868AF0-F6E4-4D76-A33C-81254D526B45 @default.
- Q92123654 P433 Q92123654-3E63BBC2-A667-43B5-9B52-D91B3D57C750 @default.
- Q92123654 P478 Q92123654-2FDAF513-3E1D-44F6-AEBD-F6BFC9BF5621 @default.
- Q92123654 P577 Q92123654-FDE767AB-C990-47D2-A3E2-8D37381B1086 @default.
- Q92123654 P698 Q92123654-D71643D3-5EBD-4249-9273-E7986699ED79 @default.
- Q92123654 P356 J.DMPK.2019.01.002 @default.
- Q92123654 P698 31101589 @default.
- Q92123654 P1433 Q18019459 @default.
- Q92123654 P1476 "Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition" @default.
- Q92123654 P2093 "Alessandro Mazzetti" @default.
- Q92123654 P2093 "Caridad Rosette" @default.
- Q92123654 P2093 "Cesare Hassan" @default.
- Q92123654 P2093 "Frances J Agan" @default.
- Q92123654 P2093 "Luigi Moro" @default.
- Q92123654 P2093 "Mara Gerloni" @default.
- Q92123654 P2093 "Niccolette Rosette" @default.
- Q92123654 P304 "172-180" @default.
- Q92123654 P31 Q13442814 @default.
- Q92123654 P356 "10.1016/J.DMPK.2019.01.002" @default.
- Q92123654 P433 "3" @default.
- Q92123654 P478 "34" @default.
- Q92123654 P577 "2019-01-17T00:00:00Z" @default.
- Q92123654 P698 "31101589" @default.